Company Registration No. 12390782 (England and Wales)
Newcastle Renal Complement Therapeutics Consulting Limited
Unaudited accounts
for the year ended 31 January 2026
Newcastle Renal Complement Therapeutics Consulting Limited
Annual report and unaudited accounts
for the year ended 31 January 2026
Newcastle Renal Complement Therapeutics Consulting Limited
Company Information
for the year ended 31 January 2026
Company Number
12390782 (England and Wales)
Registered Office
1 WINDSOR AVENUE
NEWCASTLE UPON TYNE
NE3 1PS
UNITED KINGDOM
Accountants
Blueface Consulting Ltd
Mill Farm
Allendale
Hexham
Northumberland
NE47 9EQ
Chartered Accountants' report to the board of directors on the preparation of the unaudited statutory accounts of Newcastle Renal Complement Therapeutics Consulting Limited for the year ended 31 January 2026
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of
Newcastle Renal Complement Therapeutics Consulting Limited for the year ended
31 January 2026 as set out on pages
5 -
5 from the company's accounting records and from information and explanations you have given us.
As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at icaew.com/membershandbook.
This report is made solely to the Board of Directors of Newcastle Renal Complement Therapeutics Consulting Limited, as a body, in accordance with the terms of our engagement letter dated 27 July 2021. Our work has been undertaken solely to prepare for your approval the accounts of Newcastle Renal Complement Therapeutics Consulting Limited and state those matters that we have agreed to state to the Board of Directors of Newcastle Renal Complement Therapeutics Consulting Limited, as a body, in this report in accordance with AAF 07/16 as detailed at icaew.com/compilation. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Newcastle Renal Complement Therapeutics Consulting Limited and its Board of Directors as a body for our work or for this report.
It is your duty to ensure that Newcastle Renal Complement Therapeutics Consulting Limited has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit of Newcastle Renal Complement Therapeutics Consulting Limited. You consider that Newcastle Renal Complement Therapeutics Consulting Limited is exempt from the statutory audit requirement for the year.
We have not been instructed to carry out an audit or a review of the accounts of Newcastle Renal Complement Therapeutics Consulting Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts.
Blueface Consulting Ltd
Chartered Accountants
Mill Farm
Allendale
Hexham
Northumberland
NE47 9EQ
23 October 2026
Newcastle Renal Complement Therapeutics Consulting Limited
Statement of Financial Position
as at 31 January 2026
Current assets
98,064
71,294
Creditors: amounts falling due within one year
(6,458)
(3,823)
Net current assets
91,606
67,471
Total assets less current liabilities
91,606
67,471
Capital and reserves
91,606
67,471
Newcastle Renal Complement Therapeutics Consulting Limited is a private company, limited by shares, registered in England and Wales, registration number 12390782. The registered office is 1 WINDSOR AVENUE, NEWCASTLE UPON TYNE, NE3 1PS, UNITED KINGDOM.
2 Average number of employees
During the year the average number of employees was 0 (2025: 0).
For the year ending 31 January 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and FRS 105, The Financial Reporting Standard applicable to the Micro-entities Regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
Approved by the board on 26 October 2026
David Kavanagh
Director
Company Registration No. 12390782